Jayamas Medica Industri
PT Jayamas Medica Industri Tbk manufactures and sells medical devices in Indonesia, the United States of America, and South America. The company operates through three segments: Manufacturing, Distribution, and Retail. It offers medical disposables and consumables comprising medical gloves, syringes, masks, gauze, bandages, urine bag, foley catheter, alcoholic tissue, etc.; antiseptic and disinfe… Read more
Jayamas Medica Industri (OMED) - Total Liabilities
Latest total liabilities as of September 2025: Rp390.05 Billion IDR
Based on the latest financial reports, Jayamas Medica Industri (OMED) has total liabilities worth Rp390.05 Billion IDR as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Jayamas Medica Industri - Total Liabilities Trend (2019–2024)
This chart illustrates how Jayamas Medica Industri's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Jayamas Medica Industri Competitors by Total Liabilities
The table below lists competitors of Jayamas Medica Industri ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
FingerMotion Inc
NASDAQ:FNGR
|
USA | $43.71 Million |
|
Eolus Vind AB (publ)
ST:EOLU-B
|
Sweden | Skr983.00 Million |
|
Indústrias Romi S.A
SA:ROMI3
|
Brazil | R$1.35 Billion |
|
Alembic Limited
NSE:ALEMBICLTD
|
India | ₹1.91 Billion |
|
Sun Max Tech Ltd
TW:6591
|
Taiwan | NT$1.29 Billion |
|
Adagene Inc
NASDAQ:ADAG
|
USA | $28.61 Million |
|
THN Corporation
KO:019180
|
Korea | ₩387.13 Billion |
|
ARTHA RESOURCES
F:16T
|
Germany | €141.91 Million |
Liability Composition Analysis (2019–2024)
This chart breaks down Jayamas Medica Industri's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 13.93 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 4.04 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.15 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.13 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Jayamas Medica Industri's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Jayamas Medica Industri (2019–2024)
The table below shows the annual total liabilities of Jayamas Medica Industri from 2019 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | Rp329.64 Billion | -1.91% |
| 2023-12-31 | Rp336.07 Billion | -23.25% |
| 2022-12-31 | Rp437.90 Billion | -8.95% |
| 2021-12-31 | Rp480.96 Billion | +3.21% |
| 2020-12-31 | Rp466.01 Billion | +97626.91% |
| 2019-12-31 | Rp476.85 Million | -- |